Sustained interaction: The new normal for stem cell repositories?

Regenerative Medicine

Volumn 6, Issue 6, 2011, Pages 783-792

  Isasi, Rosario ^a   Knoppers, Bartha M ^a   Lomax, Geoffrey ^b  

^a MCGILL UNIVERSITY   (Canada)

^b California Institute for Regenerative Medicine   (United States)

Author keywords

best practice; biobank; cell repository; ethics; policy; stem cell; traceability

Indexed keywords

ACCESS TO INFORMATION; HEALTH CARE POLICY; HUMAN; INFORMED CONSENT; MEDICAL INFORMATION; PATIENT AUTONOMY; PATIENT SAFETY; PRIORITY JOURNAL; PRIVACY; QUALITY CONTROL; RESEARCH ETHICS; REVIEW; STEM CELL RESEARCH;

ANONYMS AND PSEUDONYMS; COOPERATIVE BEHAVIOR; HUMANS; STEM CELLS; TISSUE BANKS; TISSUE DONORS;

EID: 82955197442     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.93     Document Type: Review

References (42)

1. Fraga AM, Sukoyan M, Rajan P et al. Establishment of a Brazilian line of human embryonic stem cells in defined medium - implications for cell therapy in an ethnically diverse population. Cell Transplant. 20(3), 431-440 (2011)
2. Brennand KJ, Simone A, Jou Jet al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473(7346), 221-225(2011)
3. Luong MX, Auerbach J, Crook JM et al. A call to standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell 8(4), 357-359 (2011).Proposes a common nomenclature for future human embryonic stem and induced pluripotent (iPS) cell lines as a means to avoid further ambiguities from multiple names being applied to the same stem cell lines
4. Roth D. A third seat at the table: An insider's perspective on patient representatives. Hastings Cent. Rep. 41(1), 29-31 (2011).Makes a persuasive case to include patient advocates alongside industry members and health professionals in the decision-making procedures concerning how medical products are regulated and delivered responsibly
5. Crook JM, Hei D, Stacey G. The international stem cell banking initiative (ISCBI): Raising standards to bank on. In Vitro Cell. Dev. Biol. Anim. 46(34), 169-172 (2010).Provides an overview of the International Stem Cell Banking Initiative, which seeks to promote a network of stem cell banks across the world to facilitate best practices in stem cell research
6. Knoppers BM, Isasi R. Stem cell banking: Between traceability and identifiability. Genome Med. 2(10), 73 (2010).Provides an overview of the stem cell banking landscape, examining the challenges relating to the international sharing of stem cells and the difficulties in stem bank collaboration across different jurisdictions
7. California Institute for Regenerative Medicine. Summary and Recommendations of the CIRM Human iPS Cell Banking Workshop. California Institute for Regenerative Medicine, San Francisco, CA, USA (2010).Highlights the main conclusions from a 2 day workshop that discussed the value in supporting iPS cell banking efforts in California, USA, the need for iPS cells and banks, and the elements that would increase the impact of banks on the development of cures and therapies
8. The International Stem Cell Banking Initiative. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev. 5(4), 301-314 (2009)
9. O'Rourke PP, Abelman M, Heffernan KG. Centralized banks for human embryonic stem cells: A worthwhile challenge. Cell Stem Cell 2(4), 307-312 (2008) (Pubitemid 351455246)
10. Gertz R. Withdrawing from participating in a biobank - a comparative study. Eur. J. Health Law 15(4), 381-389 (2008)
11. Canadian Institutes for Health Research Working Group. Human Pluripotent Stem Cell Research: Recommendations for CIHR-Funded Research. Canadian Institutes for Health Research, Ottawa, Canada (2002)
12. Hegelsson G, Dillner J, Carlson J, Bartram CR, Hansson MG. Ethical framework for previously collected biobanks samples. Nat. Biotechnol. 25(9), 973-976 (2007) (Pubitemid 47517629)
13. Diaferia GR, Cardano M, Cattaneo M et al. The science of stem cell biobanking: Investing in the future. J. Cell. Physiol. DOI: 10.1002/jcp.22732 (2011) (Epub ahead of print)
14. Isasi RM, Knoppers BM. Governing stem cell banks and registries: Emerging issues. Stem Cell Res. 3(2-3), 96-105 (2009)
15. Aalto-Setala K, Conklin BR, Lo B. Obtaining consent for future research with induced pluripotent cells: Opportunities and challenges. PLoS Biol. 7(2), e42 (2009)
16. Lo B, Parham L, Alvarez-Buylla A et al. Cloning mice and men: Prohibiting the use of iPS cells for human reproductive cloning. Cell Stem Cell 6(1), 16-20 (2010)
17. National Research Council and Institute of Medicine. 2008 Amendments to the National Academies' Guidelines for Human Embryonic Stem Cell Research. National Academies Press, Washington, DC, USA (2005)
18. Lo B, Parham L, Broom C et al. Importing human pluripotent stem cell lines derived at another institution: Tailoring review to ethical concerns. Cell Stem Cell 4(2), 115-123 (2009)
19. Streiffer R. Informed consent and federal funding for stem cell research. Hastings Cent. Rep. 38(3), 40-47 (2008)
20. Conrad S, Renninger M, Hennenlotter J et al. Generation of pluripotent stem cells from adult human testis. Nature 460(7220), 344-349 (2009). Erratum in: Nature 460(7258), 1044 (2009)
21. Editorial. Common consent. Nature 460, 933 (2009)
22. Resnik DB. Re-consenting human subjects: Ethical, legal and practical issues. J. Med. Ethics 35, 656-657 (2009)
23. Ebert AD, Svendsen CN. Stem cell model of spinal muscular atrophy. Arch. Neurol. 67(6), 665-669 (2010)
24. Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur. Respir. J. 30(2), 373-382 (2007) (Pubitemid 47194191)
25. Tassé AM, Budin-Ljøsne I, Knoppers BM, Harris JR. Retrospective access to data: The ENGAGE consent experience. Eur. J. Hum. Genet. 18(7), 741-745 (2010)
26. Mello MM, Wolf LE. The Havasupai Indian tribe case - lessons for research involving stored samples. N. Eng. J. Med. 363(3), 204-207 (2010)
27. Tasha K, Freeman HA, Behr B et al. Donation of embryos for human development and stem cell research. Cell Stem Cell 8(4), 360-362 (2011)
28. Franklin SB, Hunt C, Cornwell G et al. hESCCO: Development of good practice models for hES cell derivation. Fut. Med. 3(1), 105-116 (2008) (Pubitemid 351541194)
29. Salvaterra E, Lecchi L, Giovanelli S et al. Banking together. EMBO Rep. 9(4), 307-313 (2008)
30. European Group on Ethics in Science and New Technologies to the European Commission. Recommendations on the Ethical Review of hESC FP7 Research Projects. Opinion No. 22. European Communities (2007)
31. EU. Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 of 13 November 2007. L324/121-L324/137 (2007)
32. WHO. WHO guiding principles on human cell, tissue and organ transplantation. Transplantation 90(3), 229-233 (2010)
33. Department of Biotechnology; Indian Council of Medical Research. National Guidelines for Stem Cell Research and Therapy. Director General, Indian Council of Medical Research, New Delhi, India (2007)
34. Ashford P. Traceability. Cell Tissue Bank 11(4), 329-333 (2010)
35. EC. Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. L38/42-L38/52 (2006)
36. Spain. Law 14/2007 on Biomedical Research. 3 July 2007
37. Human Fertilisation and Embryology Authority. HFEA Code of Practice (8th Edition). Human Fertilisation and Embryology Authority, London, UK (2009)
38. Eriksson S, Helgesson G. Potential harms, anonymization, and the right to withdraw consent to biobank research. Eur. J. Hum. Genet. 13(9), 1071-1076 (2005) (Pubitemid 43073615)
39. US FDA. Guidance for Sponsors, Clinical Investigators, and IRBS. Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials. US FDA, Rockville, MD, USA (2008)
40. World Medical Association. World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. World Medical Association General Assembly, Seoul, Korea (2008)
41. William R, Watson G, Kay EW et al. Integrating biobanks: Addressing the practical and ethical issues to deliver a valuable tool for cancer research. Nat. Rev. Cancer 10(9), 646-651 (2010)
42. Caulfield T, Ogbogu O, Isasi RM. Informed consent and embryonic stem cell research: Are we following basic consent principles? CMAJ 176(12), 1722-1725 (2007). (Pubitemid 46903979)